Sangamo Therapeutics
SGMO
#10618
Rank
HK$0.24 B
Marketcap
HK$0.58
Share price
0.00%
Change (1 day)
-88.86%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total debt

Total debt on the balance sheet as of March 2026 : HK$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total debt is HK$0.15 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$0.20 B-12.14%
2024-12-31HK$0.23 B-20.26%
2023-12-31HK$0.29 B-11.64%
2022-12-31HK$0.33 B-10.16%
2021-12-31HK$0.37 B14.91%
2020-12-31HK$0.32 B-5.66%
2019-12-31HK$0.34 B59.5%
2018-12-31HK$0.21 B12.19%
2017-12-31HK$0.19 B531.79%
2016-12-31HK$30.59 M
2015-12-31N/A
2001-12-31HK$2.22 M
1999-12-31HK$2.33 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$384.79 B 253,551.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$449.67 B 296,320.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$65.56 B 43,119.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
HK$152.45 B 100,396.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$205.95 B 135,664.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$423.01 B 278,743.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$9.94 B 6,456.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$32.97 B 21,637.02%๐Ÿ‡บ๐Ÿ‡ธ USA